More on BIOA
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $5.35 |
|
|||
| Open | $5.35 | ||||
| 52 Wk High | $8.73 | ||||
| 52 Wk Low | $2.86 | ||||
| Day High | $5.35 | ||||
| Day Low | $4.81 | ||||
| P/E | N/A | ||||
| EPS | $-3.82 | ||||
| Volume | 868,263 | ||||
- Deep Origin Announces Multi-Target AI-Driven Drug Discovery Collaboration with BioAge Labs; Validated Hits Confirmed against First Target
- UBS Starts BioAge Labs Inc (BIOA) at Neutral
- Form 8-K BioAge Labs, Inc. For: Oct 02
- BioAge Labs to Present at Upcoming Investor Conferences
- First patient treated with Leqembi® (lecanemab) in Sweden
- Japan approves subcutaneous autoinjector form of Leqembi for Alzheimer's
- Leqembi® Pen subcutaneous formulation approved in Japan
- Leqembi Iqlik® for initiation treatment launched in the US
- BioArctic and Mesenkia enter oncology research collaboration
- Invitation to presentation of BioArctic's second quarter report for April - June 2026 on August 26 at 9:30 a.m. CEST
Entities mentioned with BIOA
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- IPO | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- Tesla | View Related Stories »
- Show More...
